AVXL - 4.02 Pre-market now at 4.55/4.65 Anavex Life Sciences Reports Positive Data from Phase 2a Trial of Anavex 2-73 to Treat Alzheimer's Disease http://stockcharts.com/c-sc/sc?s=AVXL&p=D&b=5&g=0&i=t85015511059&r=1507807578154 http://stockcharts.com/c-sc/sc?s=AVXL&p=W&b=5&g=0&i=t50537608375&r=1507807558239